Rexahn Pharmaceuticals Presents Preliminary Clinical Data for Supinoxin(TM) and RX-3117 Oncology Programs at the European Cancer Congress 2015 Sep 28, 2015
Rexahn Pharmaceuticals to Present Preliminary Clinical Data at the European Cancer Congress 2015 Sep 25, 2015
Rexahn Pharmaceuticals to Present at the 17th Annual Rodman and Renshaw Global Investment Conference on September 10, 2015 Aug 31, 2015
Rexahn Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update Aug 10, 2015
Rexahn Pharmaceuticals Awarded Patent in Japan for Novel Targeted Cancer Drug Delivery Platform Jul 14, 2015
Data on Rexahn’s RX-3117 in Non-Small Cell Lung Cancer Presented at 16th International Symposium of the Purine and Pyrimidine Society Jun 9, 2015